JP2014505107A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505107A5 JP2014505107A5 JP2013553557A JP2013553557A JP2014505107A5 JP 2014505107 A5 JP2014505107 A5 JP 2014505107A5 JP 2013553557 A JP2013553557 A JP 2013553557A JP 2013553557 A JP2013553557 A JP 2013553557A JP 2014505107 A5 JP2014505107 A5 JP 2014505107A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- halogen
- syndrome
- use according
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 239000001257 hydrogen Substances 0.000 claims 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 208000008770 Multiple Hamartoma Syndrome Diseases 0.000 claims 7
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 6
- 201000010917 PTEN hamartoma tumor syndrome Diseases 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 208000002927 Hamartoma Diseases 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- 210000004881 tumor cell Anatomy 0.000 claims 3
- 208000012609 Cowden disease Diseases 0.000 claims 2
- 201000002847 Cowden syndrome Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 229940124530 sulfonamide Drugs 0.000 claims 2
- 150000003456 sulfonamides Chemical group 0.000 claims 2
- CWHUFRVAEUJCEF-UHFFFAOYSA-N BKM120 Chemical compound C1=NC(N)=CC(C(F)(F)F)=C1C1=CC(N2CCOCC2)=NC(N2CCOCC2)=N1 CWHUFRVAEUJCEF-UHFFFAOYSA-N 0.000 claims 1
- 208000007531 Proteus syndrome Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161441896P | 2011-02-11 | 2011-02-11 | |
| US61/441,896 | 2011-02-11 | ||
| PCT/US2012/024440 WO2012109423A1 (en) | 2011-02-11 | 2012-02-09 | Method of inhibiting hamartoma tumor cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014505107A JP2014505107A (ja) | 2014-02-27 |
| JP2014505107A5 true JP2014505107A5 (enExample) | 2015-03-12 |
Family
ID=45809596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013553557A Withdrawn JP2014505107A (ja) | 2011-02-11 | 2012-02-09 | 過誤腫性腫瘍細胞を阻害する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140309221A1 (enExample) |
| EP (1) | EP2673268A1 (enExample) |
| JP (1) | JP2014505107A (enExample) |
| KR (1) | KR20140063509A (enExample) |
| CN (1) | CN103476765A (enExample) |
| AU (1) | AU2012214413A1 (enExample) |
| BR (1) | BR112013020159A2 (enExample) |
| CA (1) | CA2826387A1 (enExample) |
| MX (1) | MX2013009256A (enExample) |
| RU (1) | RU2013141559A (enExample) |
| WO (1) | WO2012109423A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| JP6026544B2 (ja) | 2011-09-27 | 2016-11-16 | ノバルティス アーゲー | 変異体ｉｄｈの阻害剤としての３−ピリミジン−４−イル−オキサゾリジン−２−オン類 |
| UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
| US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
| CN103012284A (zh) * | 2012-12-26 | 2013-04-03 | 无锡捷化医药科技有限公司 | 一种2-氨基-5-溴嘧啶类化合物的制备方法 |
| GEP201706699B (en) | 2013-03-14 | 2017-07-10 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| CA2944697C (en) | 2014-04-22 | 2022-07-19 | Universitaet Basel | Manufacturing process for triazine, pyrimidine and pyridine derivatives |
| CN105001151B (zh) * | 2015-08-28 | 2017-07-14 | 苏州明锐医药科技有限公司 | 布帕尼西中间体及其制备方法 |
| JP7118509B2 (ja) * | 2016-05-18 | 2022-08-16 | トルク アーゲー | 皮膚病変の治療 |
| EP3458035A1 (en) * | 2016-05-18 | 2019-03-27 | PIQUR Therapeutics AG | Treatment of skin lesions |
| CN106905294A (zh) * | 2016-07-08 | 2017-06-30 | 苏州科睿思制药有限公司 | 5‑[2,6‑二(4‑吗啉基)‑4‑嘧啶基]‑4‑(三氟甲基)‑2‑吡啶胺的晶型及其制备方法 |
| CN106632443B (zh) * | 2016-11-23 | 2022-06-17 | 山东友帮生化科技有限公司 | 一种2-氨基嘧啶-5-硼酸频哪酯硼酸盐的合成方法 |
| RU2020115351A (ru) * | 2017-11-23 | 2021-12-23 | Пикур Терапьютикс Аг | Лечение кожных заболеваний |
| CN114213340B (zh) | 2022-02-22 | 2022-06-07 | 北京蓝晶微生物科技有限公司 | 2,4-二氨基嘧啶氧化物的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| CN102548970B (zh) * | 2009-07-02 | 2015-11-25 | 赛诺菲 | 新型(6-氧代-1,6-二氢嘧啶-2-基)酰胺衍生物、其制备方法以及其作为akt(pkb)磷酸化抑制剂的医药用途 |
-
2012
- 2012-02-09 RU RU2013141559/04A patent/RU2013141559A/ru not_active Application Discontinuation
- 2012-02-09 JP JP2013553557A patent/JP2014505107A/ja not_active Withdrawn
- 2012-02-09 US US13/984,422 patent/US20140309221A1/en not_active Abandoned
- 2012-02-09 BR BR112013020159A patent/BR112013020159A2/pt not_active IP Right Cessation
- 2012-02-09 MX MX2013009256A patent/MX2013009256A/es not_active Application Discontinuation
- 2012-02-09 AU AU2012214413A patent/AU2012214413A1/en not_active Abandoned
- 2012-02-09 EP EP12707171.0A patent/EP2673268A1/en not_active Withdrawn
- 2012-02-09 CN CN201280013673XA patent/CN103476765A/zh active Pending
- 2012-02-09 WO PCT/US2012/024440 patent/WO2012109423A1/en not_active Ceased
- 2012-02-09 CA CA2826387A patent/CA2826387A1/en not_active Abandoned
- 2012-02-09 KR KR1020137023617A patent/KR20140063509A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505107A5 (enExample) | ||
| RU2013141559A (ru) | Способ ингибирования клеток опухоли гамартомы | |
| JP2013510120A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2014518266A5 (enExample) | ||
| JP2016536286A5 (enExample) | ||
| JP2019517487A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2015511638A5 (enExample) | ||
| JP2017518334A5 (enExample) | ||
| JP2010530431A5 (enExample) | ||
| JP2013510123A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2010504344A5 (enExample) | ||
| JP2014508804A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2011037901A5 (enExample) | ||
| JP2015515475A5 (enExample) | ||
| JP2017505293A5 (enExample) | ||
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
| JP2014503593A5 (enExample) | ||
| JP2008534453A5 (enExample) |